Hypoxia Increases the Efficiencies of Cellular Reprogramming and Oncogenic Transformation in Human Blood Cell Subpopulations In Vitro and In Vivo
Cells · 2024
DOI: 10.3390/cells13110971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Adrián Moratilla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cell Engineering Laboratory, La Paz University Hospital Health Research Institute, IdiPAZ, 28046 Madrid, Spain. Hauptthemen laut MEDLINE: Cellular Reprogramming, Induced Pluripotent Stem Cells, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Domingo Martínez, Foundation Jesus Antolín Garciarena, European Social Fund.
Abstract (Originalsprache)
Patients with chronic hypoxia show a higher tumor incidence; however, no primary common cause has been recognized. Given the similarities between cellular reprogramming and oncogenic transformation, we directly compared these processes in human cells subjected to hypoxia. Mouse embryonic fibroblasts were employed as controls to compare transfection and reprogramming efficiency; human adipose-derived mesenchymal stem cells were employed as controls in human cells. Easily obtainable human peripheral blood mononuclear cells (PBMCs) were chosen to establish a standard protocol to compare cell reprogramming (into induced pluripotent stem cells (iPSCs)) and oncogenic focus formation efficiency. Cell reprogramming was achieved for all three cell types, generating actual pluripotent cells capable for differentiating into the three germ layers. The efficiencies of the cell reprogramming and oncogenic transformation were similar. Hypoxia slightly increased the reprogramming efficiency in all the cell types but with no statistical significance for PBMCs. Various PBMC types can respond to hypoxia differently; lymphocytes and monocytes were, therefore, reprogrammed separately, finding a significant difference between normoxia and hypoxia in monocytes in vitro. These differences were then searched for in vivo. The iPSCs and oncogenic foci were generated from healthy volunteers and patients with chronic obstructive pulmonary disease (COPD). Although higher iPSC generation efficiency in the patients with COPD was found for lymphocytes, this increase was not statistically significant for oncogenic foci. Remarkably, a higher statistically significant efficiency in COPD monocytes was demonstrated for both processes, suggesting that physiological hypoxia exerts an effect on cell reprogramming and oncogenic transformation in vivo in at least some cell types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Engineering Laboratory, La Paz University Hospital Health Research Institute, IdiPAZ, 28046 Madrid, Spain.
- Internal Medicine Service, La Paz University Hospital, IdiPAZ, 28046 Madrid, Spain.
ORCID-Profile: Francisco Arnalich, Maria P De Miguel
Förderung
- Foundation Domingo Martínez
- Foundation Jesus Antolín Garciarena
- European Social Fund
- Foundations Domingo Martínez
- Jesus Antolín Garciarena
- Ministry of Education, Youth, and Sports of Madrid
Zitieren
APA
Moratilla, A., Martín, D., Cadenas-Martín, M., Stokking, M., Quesada, M. A., Arnalich, F., & De Miguel, M. P. (2024). Hypoxia Increases the Efficiencies of Cellular Reprogramming and Oncogenic Transformation in Human Blood Cell Subpopulations In Vitro and In Vivo. Cells. https://doi.org/10.3390/cells13110971
Vancouver
Moratilla A, Martín D, Cadenas-Martín M, Stokking M, Quesada MA, Arnalich F, et al. Hypoxia Increases the Efficiencies of Cellular Reprogramming and Oncogenic Transformation in Human Blood Cell Subpopulations In Vitro and In Vivo. Cells. 2024. doi:10.3390/cells13110971
BibTeX
@article{Moratilla2024,
author = {Moratilla, Adrián and Martín, Diana and Cadenas-Martín, Marta and Stokking, Martha and Quesada, Maria Angustias and Arnalich, Francisco and De Miguel, Maria P},
title = {Hypoxia Increases the Efficiencies of Cellular Reprogramming and Oncogenic Transformation in Human Blood Cell Subpopulations In Vitro and In Vivo},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13110971}
}
EUVIMED